[Medical economics in year 2001 as exemplified by Helicobacter pylori]

Internist (Berl). 2001 Apr;42(4):465-9, 471-2. doi: 10.1007/s001080050781.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents
  • Clinical Protocols
  • Cost-Benefit Analysis
  • Disease Management
  • Drug Costs
  • Drug Therapy, Combination / economics
  • Drug Therapy, Combination / therapeutic use
  • Economics, Medical / trends*
  • Family Practice / economics*
  • Germany
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / economics*
  • Helicobacter pylori
  • Humans
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians' / economics*
  • Practice Patterns, Physicians' / standards

Substances

  • Anti-Bacterial Agents